Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Current health news highlights include Nigeria's Lassa fever fight after nearly 100 deaths, WHO's response to U.S. funding ...

The world grapples with multiple health challenges, from Nigeria's Lassa fever outbreak to the WHO adjusting to U.S. funding cuts. Amid these global health issues, the U.S. addresses domestic and ...

GE Aerospace is the latest company to announce an investment in the U.S. economy under the Trump administration. GE said the ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Though Kennedy, an anti-vaccine conspiracy theorist, has vocally criticized Big Pharma and its political influence, the ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...